It has been reported that CCR5 expression is increased in the myeloma microenvironment, leading to leukocyte chemotaxis, immunosuppression, and tumor cell migration and infiltration, ultimately promoting tumor proliferation and spread. This evidence concerns the gene CCR5 and plasma cell myeloma.